Ceftaroline
Paul A. Pham, Pharm.D. BCPS
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Acute bacterial skin and skin structure infections (ABSSSIs)
Due to susceptible organisms:
S. aureus
(including MRSA),
S. pyogenes, S. agalactiae,
E.coli
,
K. pneumoniae
, K. oxytoca.
Community acquired pneumonia
(including cases caused by PCN-resistant
S. pneumoniae
)
Due to susceptible organisms:
S. pneumoniae
(including cases with bacteremia)
,
MSSA,
H. influenzae
, K. pneumoniae,
E. coli
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
MRSA infections not listed above
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved